Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2025-12-29 @ 10:55 PM
Study NCT ID:
NCT05582304
Status:
COMPLETED
Last Update Posted:
2024-01-31
First Post:
2022-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study
Sponsor:
Johnson & Johnson Vision Care, Inc.
Organization:
Study Overview
Official Title:
Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This will be a split-plot design, randomized, parallel, double-masked feasibility study to evaluate the role of a test lens on contrast sensitivity with and without glare.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: